Theranostics is a personalised cancer treatment combining diagnostics and therapies. It uses PET scan imaging to detect tumor receptors on cancer cells. If receptors are present, a radioactive drug selectively targets and treats the tumour cells while sparing healthy tissues.
AI is rapidly transforming theranostics, enhancing cancer diagnosis and treatment with precision and efficiency. By integrating AI, theranostics enables more accurate diagnoses and personalised therapies through data analysis and predictive modelling.
It also supports clinicians and patients in identifying new radiopharmaceutical targets and accelerating drug discovery. However, challenges like data security, accountability, and inclusivity hinder widespread adoption.
Further research and guidelines are needed to address these issues and fully realise AI's potential in clinical workflows. Perpetual is here to support your needs with our suite of services specific to theranostics, including leveraging AI for best practice.
Photo by UCLA Health
at: https://www.uclahealth.org/cancer/cancer-services/theranostics
Explore our offerings for theranostics.
Perpetual Scientific collaborates with you to design robust study protocols supported by adequate pre-clinical and clinical data. We also assist in vendor selection and management, ensure timely data delivery, and develop frameworks to comply with ICH GCP guidelines.
Get startedWe help you understand your audience, craft unique value propositions, and leverage digital media, networks, and opinion leaders to build awareness, drive adoption, and establish trust in precision medicine.
Conferences showcase cutting-edge research, build trust, and engage healthcare providers. Perpetual delivers impactful content, including research, workshops, and demos, tailored to diverse healthcare systems for effective education and engagement.
Publications foster knowledge and adoption through peer-reviewed articles, case studies, and white papers. We also highlight economic analyses and policy recommendations to advocate for theranostics integration into healthcare.